Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Industry News

Related Searches:

Filter by:

MedImmune Licenses Vaccine Technology To Japan's Biken
September 30, 2008
MedImmune has licensed its reverse genetics technology to Biken, The Research Foundation for Microbial Diseases of Osaka University in Japan, for the development of new vaccine strains to produce non-live human influenza vaccines. Reverse genetics is…   Read More »
ABC Labs Opens New Development Facility
September 30, 2008
Analytical Bio-Chemistry Labs (ABC Labs) opened its new 90,000- sq.-ft. pharmaceutical development facility located at the University of Missouri’s Discovery Ridge Research Park, completing the transition of the company’s DMPK, bioanalyti…   Read More »
Cardinal To Spin-Off Clinical And Medical Products Businesses
September 29, 2008
Cardinal Health plans to spin-off its clinical and medical products businesses as a separate public company that will be led by current vice chairman David L. Schlotterbeck. The spin-off is expected to be completed by mid-2009. This plan is an effort…   Read More »
SAFC Pharma Commissions New HPAPI Facility
September 29, 2008
SAFC Pharma has commissioned a new suite at its St. Louis campus that will produce high-potency active pharmaceutical ingredient (HPAPI) conjugates to support oncology drug development. The 600-sq.-ft. suite will enable the conjugation of HPAPIs…   Read More »
SAFC Pharma Completes API Expansion
September 29, 2008
SAFC Pharma’s new reactor at its Arklow, manufacturing site has begun operation, expanding the facility's capacity for large-scale active pharmaceutical ingredient (API) manufacturing by approximately 15%. The $4 million project involve…   Read More »
Ligand To Buy Pharmacopeia
September 25, 2008
Ligand Pharmaceuticals has entered into a merger agreement to acquire Pharmacopeia, in an all-stock deal valued at $70 million. In addition to the share value, Pharmacopeia stockholders will be entitled to a Contingent Value Right (“CVR”)…   Read More »
InVentiv Expands European Operations With Madrid Office
September 24, 2008
inVentiv Clinical Solutions, LLC, a division of inVentiv Health, has continued its expansion outside North America with a new office in Madrid. The company plans to expand operations to other European countries, including Eastern Europe. inVentiv…   Read More »
Parexel Expands Early Phase Capabilities
September 23, 2008
Parexel has expanded its early phase drug development capabilities with a dedicated unit to provide biopharmaceutical companies with support for proof-of-concept studies. The new unit integrates capabilities in regulatory strategies, drug development…   Read More »
Tris Pharma Completes Expansion, Gains FDA Clearance
September 23, 2008
Tris Pharma has completed the expansion of its research and manufacturing facility in South Brunswick, NJ. The expansion provides 15,000 sq. ft. of additional space to the facility and is FDA-compliant with cGMP. It allows for additional commercial-s…   Read More »
Schering-Plough To Cut 1,000 U.S. Reps
September 22, 2008
Schering-Plough plans to cut 20% of its U.S. sales force by October 1 as part of a previously announced restructuring plan aimed at saving $1.5 billion by late 2012. The company said it will eliminate 1,000 sales positions from its U.S. Primary Care…   Read More »
Genzyme Opens New Science Center
September 22, 2008
Genzyme Corp. opened its new Science Center in Framingham, MA. The facility serves as a central site for early stage research to discover new treatments for diseases such as Parkinson's, cancer, and heart disease. The Science Center has received a Go…   Read More »
Laureate Adds Manufacturing Capacity
September 19, 2008
Laureate Pharma, Inc. is increasing its manufacturing capacity with the addition of two Single-Use Bioreactors (S.U.B.), a 250L and a 1000L S.U.B.  The S.U.B. is a single-use alternative to stirred tank bioreactors. The S.U.B. consists of a perm…   Read More »
Bilcare GCS Completes Facility Expansion
September 18, 2008
Bilcare Global Clinical Supplies has completed the expansion of its warehouse and distribution facility in Phoenixville, PA. The facility now provides 300% more ambient storage capacity, as well as a 50% larger distribution pack-out area, and a secon…   Read More »
Crucell, Talecris Biotherapeutics Sign License Agreement
September 18, 2008
Crucell has signed an exclusive, commercial license agreement with NC-based Talecris Biotherapeutics for an undisclosed protein to be produced using the PER.C6 cell line. Crucell will receive an upfront payment of $2.5 million and will be eligible fo…   Read More »
Valeant To Acquire Coria Labs
September 17, 2008
Valeant Pharmaceuticals has signed a definitive agreement to acquire Coria Laboratories, Ltd., a specialty pharmaceutical company focused on dermatology products in the U.S., for $95 million. This acquisition expands Valeant’s U.S. business and…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: